
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES144
The ASCOT-BPLA study found that for the diabetes subgroup for total CV events and
procedures there was significantly lower occurrence with the amlodipine based group vs the
atenolol based group (HR 0.87, 0.76 to 0.99, p=0.0283), this was also found for the nondiabetic
study participants.262 Level 1++

[@Pepine_2004]

